Discover the complete record of transactions filed by LIONEL RIVET, Chief Executive Officer. Officer active across 1 companies, notably LISI. Aggregated, 10 disclosures have been logged. Total volume traded: €81k. The latest transaction was filed on 30 July 2025 — Cession d'actions gratuites. Regulator: AMF. The full history is accessible without signup.
10 of 10 declarations
Lionel Rivet is a senior executive within the French industrial group LISI, where he serves as Chief Executive Officer of LISI MEDICAL. He also sits on the LISI Group Executive Committee, which is responsible for steering the group’s overall strategy and operational priorities. His career path inside LISI shows a steady rise in responsibility: in 2020 he was identified as Chief Operating Officer for the medical division, in 2021 as Deputy CEO of LISI MEDICAL, and by 2023 and 2024 he was presented as CEO of the division. This progression reflects long-term operational experience and growing leadership influence within one of the group’s key businesses. At LISI MEDICAL, Rivet oversees a business focused on two strategic markets: minimally invasive surgery (MIS) instruments and orthopedic reconstruction implants. Under his leadership, the division has emphasized organic growth, continuous improvement, and the industrial modernization of its sites. In the group’s 2023 integrated report, he highlighted strong growth supported by a robust position in the United States and solid momentum in Europe, while stressing the importance of significant investments in quality, cost control, and customer service. He also described a first automation wave that had already been completed and delivered meaningful productivity gains, followed by a second wave of robotization targeting more complex production stages. His management approach combines industrial performance with long-term sustainability. In 2023, he set out concrete goals related to energy savings, solar power generation, electric vehicle charging infrastructure, and social governance, including an ambition to reach 30% female managers and to assess more than 70% of suppliers against CSR criteria. He also articulated a medium-term revenue ambition of surpassing €300 million. Lionel Rivet therefore stands out as an execution-focused industrial leader, blending operational excellence, process innovation, and environmental responsibility in a highly regulated medical-device environment.